First Heartland Consultants’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Buy
+2,477
New +$221K 0.02% 517
2026
Q1
Sell
-3,043
Closed -$241K 537
2025
Q4
$241K Buy
3,043
+5
+0.2% +$394 0.02% 474
2025
Q3
$229K Buy
3,038
+33
+1% +$2.26K 0.02% 474
2025
Q2
$207K Sell
3,005
-964
-24% -$63.2K 0.02% 477
2025
Q1
$269K Buy
+3,969
New +$238K 0.03% 366
2024
Q4
Sell
-4,571
Closed -$287K 459
2024
Q3
$287K Sell
4,571
-88
-2% -$5.13K 0.03% 340
2024
Q2
$275 Buy
4,659
+465
+11% +$29.1K 0.02% 362
2024
Q1
$334K Sell
4,194
-937
-18% -$71.6K 0.03% 317
2023
Q4
$405K Sell
5,131
-283
-5% -$20.1K 0.05% 245
2023
Q3
$378K Buy
5,414
+3
+0.1% +$213 0.05% 250
2023
Q2
$374K Sell
5,411
-620
-10% -$44.1K 0.05% 251
2023
Q1
$448K Sell
6,031
-640
-10% -$53.7K 0.07% 220
2022
Q4
$622K Sell
6,671
-125
-2% -$12.1K 0.1% 171
2022
Q3
$648 Buy
6,796
+813
+14% +$80.5K 0.06% 159
2022
Q2
$554K Sell
5,983
-37
-0.6% -$3.61K 0.09% 179
2022
Q1
$609K Buy
6,020
+167
+3% +$17.5K 0.09% 162
2021
Q4
$603 Buy
5,853
+552
+10% +$51K 0.02% 170
2021
Q3
$450K Buy
5,301
+240
+5% +$20.1K 0.07% 217
2021
Q2
$422K Sell
5,061
-1,787
-26% -$146K 0.06% 237
2021
Q1
$515K Buy
6,848
+3,111
+83% +$227K 0.08% 197
2020
Q4
$255K Buy
+3,737
New +$243K 0.04% 278
2020
Q2
Sell
-15,657
Closed -$929K 287
2020
Q1
$929K Sell
15,657
-2,621
-14% -$175K 0.24% 93
2019
Q4
$1.36M Sell
18,278
-9,469
-34% -$665K 0.27% 93
2019
Q3
$1.75M Sell
27,747
-1,690
-6% -$100K 0.38% 68
2019
Q2
$1.6M Buy
29,437
+543
+2% +$29.2K 0.39% 66
2019
Q1
$1.56M Buy
28,894
+1,157
+4% +$71.4K 0.44% 57
2018
Q4
$1.82M Sell
27,737
-4,055
-13% -$303K 0.68% 49
2018
Q3
$2.5M Buy
31,792
+12,621
+66% +$902K 0.78% 41
2018
Q2
$1.23M Buy
19,171
+3,737
+24% +$246K 0.44% 66
2018
Q1
$960K Buy
15,434
+10,141
+192% +$728K 0.29% 89
2017
Q4
$384K Sell
5,293
-9,690
-65% -$704K 0.12% 190
2017
Q3
$1.22M Sell
14,983
-217
-1% -$17.2K 0.3% 98
2017
Q2
$1.22M Buy
15,200
+1,283
+9% +$101K 0.32% 86
2017
Q1
$1.09M Buy
13,917
+5,171
+59% +$413K 0.3% 88
2016
Q4
$690K Buy
8,746
+1,410
+19% +$114K 0.21% 135
2016
Q3
$653K Buy
7,336
+3,464
+89% +$327K 0.19% 134
2016
Q2
$371 Buy
3,872
+517
+15% +$51.5K 0.04% 189
2016
Q1
$348K Buy
3,355
+1,014
+43% +$98.6K 0.13% 177
2015
Q4
$229K Buy
2,341
+118
+5% +$11.6K 0.09% 234
2015
Q3
$214K Buy
2,223
+23
+1% +$2.42K 0.09% 226
2015
Q2
$231 Hold
2,200
0.06% 224
2015
Q1
$227K Sell
2,200
-525
-19% -$53.1K 0.09% 228
2014
Q4
$262K Buy
+2,725
New +$240K 0.11% 197

Other funds holding CVS

First Heartland Consultants's CVS Position: Q2 2026 in Review

First Heartland Consultants opened a new position in CVS Health (CVS) in Q2 2026: 2,477 shares worth $256K. The stake represents 0.02% of the portfolio and ranks #517 among its holdings. This is a return to the name: First Heartland Consultants previously reported a position in CVS as recently as Q4 2025.

First Heartland Consultants first reported a position in CVS in Q4 2014 and has held it in 43 quarters since. The position peaked at $2.5M in Q3 2018. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • First Heartland Consultants held 2,477 shares of CVS Health worth $256K as of Q2 2026.
  • CVS Health was a new First Heartland Consultants position in Q2 2026.
  • CVS Health made up 0.02% of First Heartland Consultants's portfolio in Q2 2026, its #517 holding.
  • First Heartland Consultants first reported a position in CVS Health in Q4 2014 and has held it in 43 quarters since.
  • First Heartland Consultants's CVS Health position peaked at $2.5M in Q3 2018.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.